Herbst RS, Cho BC, Zhou C, Burotto M, et al. Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous Non-Small-Cell Lung Cancer: Phase 3 LEAP-006 Study. J Thorac Oncol 2025 May 24:S1556-0864(25)00724.
PMID: 40419140